201 related articles for article (PubMed ID: 2424075)
1. Platelet alpha-granule release in chronic myeloproliferative disorders with thrombocytosis.
Sacchi S; Curci G; Piccinini L; Messerotti A; Cucci F; Bursi R; Zaniol P; Torelli U
Scand J Clin Lab Invest; 1986 Apr; 46(2):163-6. PubMed ID: 2424075
[TBL] [Abstract][Full Text] [Related]
2. Platelet factor-4 excretion in myeloproliferative disease: implications for the aetiology of myelofibrosis.
Burstein SA; Malpass TW; Yee E; Kadin M; Brigden M; Adamson JW; Harker LA
Br J Haematol; 1984 Jul; 57(3):383-92. PubMed ID: 6743563
[TBL] [Abstract][Full Text] [Related]
3. A prospective study of haemostatic parameters in relation to the clinical course of myeloproliferative disorders.
Wehmeier A; Fricke S; Scharf RE; Schneider W
Eur J Haematol; 1990 Oct; 45(4):191-7. PubMed ID: 2146144
[TBL] [Abstract][Full Text] [Related]
4. Beta-thromboglobulin (beta-TG) and platelet factor 4 (PF4) release by adenosine diphosphate (ADP) contact with native whole blood.
Pengo V; Boschello M; Prandoni P; Schivazappa L; Girolami A
Thromb Res; 1985 Sep; 39(5):645-50. PubMed ID: 2417360
[No Abstract] [Full Text] [Related]
5. Clinical significance of beta-thromboglobulin in patients with high platelet count.
Fabris F; Randi ML; Casonato A; Dal Bo Zanon R; Bonvicini P; Girolami A
Acta Haematol; 1984; 71(1):32-8. PubMed ID: 6197855
[TBL] [Abstract][Full Text] [Related]
6. A formula for correcting for the in vitro release of platelet beta-thromboglobulin.
van Wyk V; Heyns AD; de Wet JI; Kotzé HF; Lötter MG
Thromb Res; 1987 Jun; 46(5):659-68. PubMed ID: 2957816
[TBL] [Abstract][Full Text] [Related]
7. Platelet and plasma beta thromboglobulin in myeloproliferative syndromes and secondary thrombocytosis.
Boughton BJ; Allington MJ; King A
Br J Haematol; 1978 Sep; 40(1):125-32. PubMed ID: 81681
[TBL] [Abstract][Full Text] [Related]
8. Abnormal levels of platelet-specific proteins and mitogenic activity in myeloproliferative disease.
Rueda F; Piñol G; Marti F; Pujol-Moix N
Acta Haematol; 1991; 85(1):12-5. PubMed ID: 1826402
[TBL] [Abstract][Full Text] [Related]
9. Detection of enhanced in vivo platelet alpha-granule release in different patient groups--comparison of beta-thromboglobulin, platelet factor 4 and thrombospondin assays.
Lane DA; Ireland H; Wolff S; Ranasinghe E; Dawes J
Thromb Haemost; 1984 Oct; 52(2):183-7. PubMed ID: 6084323
[TBL] [Abstract][Full Text] [Related]
10. Platelet function and structure in myeloproliferative disease, myelodysplastic syndrome, and secondary thrombocytosis.
Raman BK; Van Slyck EJ; Riddle J; Sawdyk MA; Abraham JP; Saeed SM
Am J Clin Pathol; 1989 Jun; 91(6):647-55. PubMed ID: 2524965
[TBL] [Abstract][Full Text] [Related]
11. Beta-thromboglobulin content in megakaryocytes of patients with myeloproliferative diseases.
Grossi A; Vannucchi AM; Rafanelli D; Filimberti E; Rossi Ferrini P
Thromb Res; 1986 Aug; 43(3):367-74. PubMed ID: 2426823
[No Abstract] [Full Text] [Related]
12. Platelet activation in myeloproliferative disorders.
Cortelazzo S; Viero P; Barbui T
Thromb Haemost; 1981 Jun; 45(3):211-3. PubMed ID: 6169172
[TBL] [Abstract][Full Text] [Related]
13. The value of beta TG/PF4 ratio in patients with high platelet count.
Fabris F; Luzzatto G; Girolami A
Thromb Haemost; 1985 Apr; 53(2):288-9. PubMed ID: 2410998
[No Abstract] [Full Text] [Related]
14. The release of beta-thromboglobulin and platelet factor 4 during extracorporeal circulation for open heart surgery.
Cella G; Vittadello O; Gallucci V; Girolami A
Eur J Clin Invest; 1981 Jun; 11(3):165-9. PubMed ID: 6168469
[TBL] [Abstract][Full Text] [Related]
15. Does the beta TG/PF4 ratio have any value in myeloproliferative diseases?
Viero P; Cortelazzo S; Barbui T
Thromb Haemost; 1984 Jul; 51(3):411. PubMed ID: 6208631
[No Abstract] [Full Text] [Related]
16. Platelet alpha granule release in diabetes mellitus.
Sacchi S; Curci G; Piccinini L; Cucci F; Messerotti A; Roncaia R; Benedetti PG
Scand J Clin Lab Invest; 1985 Apr; 45(2):165-8. PubMed ID: 2408317
[TBL] [Abstract][Full Text] [Related]
17. Relationship between low affinity platelet factor 4 (LA-PF4) and beta-thromboglobulin (beta TG).
Niewiarowski S
Thromb Haemost; 1980 Aug; 44(1):47. PubMed ID: 6158765
[No Abstract] [Full Text] [Related]
18. Utilization of the platelet release reaction in the blood compatibility assessment of polymers.
Bowry SK; Courtney JM; Prentice CR; Douglas JT
Biomaterials; 1984 Sep; 5(5):289-92. PubMed ID: 6207864
[TBL] [Abstract][Full Text] [Related]
19. Studies of beta-thromboglobulin, platelet factor 4, and fibrinopeptide A in erythrocytosis due to cyanotic congenital heart disease.
Rosove MH; Hocking WG; Harwig SS; Perloff JK
Thromb Res; 1983 Jan; 29(2):225-35. PubMed ID: 6189239
[TBL] [Abstract][Full Text] [Related]
20. Plasma and platelet beta-thromboglobulin levels in patients with May-Hegglin anomaly.
Fabris F; Casonato A; Randi ML; Girolami A
Haemostasis; 1980; 9(2):126-30. PubMed ID: 6153630
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]